These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 17055073)
1. 2'-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus. Goris N; De Palma A; Toussaint JF; Musch I; Neyts J; De Clercq K Antiviral Res; 2007 Mar; 73(3):161-8. PubMed ID: 17055073 [TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated RNA interference against foot-and-mouth disease virus infection both in vitro and in vivo. Chen W; Liu M; Jiao Y; Yan W; Wei X; Chen J; Fei L; Liu Y; Zuo X; Yang F; Lu Y; Zheng Z J Virol; 2006 Apr; 80(7):3559-66. PubMed ID: 16537624 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus. Rosas MF; Vieira YA; Postigo R; Martín-Acebes MA; Armas-Portela R; Martínez-Salas E; Sobrino F Virology; 2008 Oct; 380(1):34-45. PubMed ID: 18694581 [TBL] [Abstract][Full Text] [Related]
4. In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks. Osiceanu AM; Murao LE; Kollanur D; Swinnen J; De Vleeschauwer AR; Lefebvre DJ; De Clercq K; Neyts J; Goris N Antiviral Res; 2014 May; 105():59-63. PubMed ID: 24583031 [TBL] [Abstract][Full Text] [Related]
5. Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus. de los Santos T; Wu Q; de Avila Botton S; Grubman MJ Virology; 2005 May; 335(2):222-31. PubMed ID: 15840521 [TBL] [Abstract][Full Text] [Related]
6. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome. Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070 [TBL] [Abstract][Full Text] [Related]
7. Analysis of foot-and-mouth disease virus replication using strand-specific quantitative RT-PCR. Horsington J; Zhang Z J Virol Methods; 2007 Sep; 144(1-2):149-55. PubMed ID: 17561277 [TBL] [Abstract][Full Text] [Related]
8. Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus. Perales C; Agudo R; Manrubia SC; Domingo E J Mol Biol; 2011 Mar; 407(1):60-78. PubMed ID: 21256131 [TBL] [Abstract][Full Text] [Related]
9. In Vitro and in Vivo Antiviral Activity of Mizoribine Against Foot-And-Mouth Disease Virus. Li SF; Gong MJ; Sun YF; Shao JJ; Zhang YG; Chang HY Molecules; 2019 May; 24(9):. PubMed ID: 31058822 [TBL] [Abstract][Full Text] [Related]
10. Lithium chloride inhibits early stages of foot-and-mouth disease virus (FMDV) replication in vitro. Zhao FR; Xie YL; Liu ZZ; Shao JJ; Li SF; Zhang YG; Chang HY J Med Virol; 2017 Nov; 89(11):2041-2046. PubMed ID: 28390158 [TBL] [Abstract][Full Text] [Related]
11. Multiplex RT-PCR detection and microarray typing of vesicular disease viruses. Lung O; Fisher M; Beeston A; Hughes KB; Clavijo A; Goolia M; Pasick J; Mauro W; Deregt D J Virol Methods; 2011 Aug; 175(2):236-45. PubMed ID: 21620898 [TBL] [Abstract][Full Text] [Related]
12. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793 [TBL] [Abstract][Full Text] [Related]
13. Epithelial distribution and replication of foot-and-mouth disease virus RNA in infected pigs. Durand S; Murphy C; Zhang Z; Alexandersen S J Comp Pathol; 2008; 139(2-3):86-96. PubMed ID: 18620703 [TBL] [Abstract][Full Text] [Related]
14. Foot-and-mouth disease virus infection in young lambs: pathogenesis and tissue tropism. Ryan E; Horsington J; Durand S; Brooks H; Alexandersen S; Brownlie J; Zhang Z Vet Microbiol; 2008 Mar; 127(3-4):258-74. PubMed ID: 17942248 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of in vitro inhibitory potential of small interfering RNAs directed against various regions of foot-and-mouth disease virus genome. Mohapatra JK; Sanyal A; Hemadri D; Tosh C; Kumar RM; Bandyopadhyay SK Biochem Biophys Res Commun; 2005 Apr; 329(3):1133-8. PubMed ID: 15752771 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic application of RNA interference against foot-and-mouth disease virus in vitro and in vivo. Kim SM; Lee KN; Park JY; Ko YJ; Joo YS; Kim HS; Park JH Antiviral Res; 2008 Nov; 80(2):178-84. PubMed ID: 18601955 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and in-vitro evaluation of 2-amino-4-arylthiazole as inhibitor of 3D polymerase against foot-and-mouth disease (FMD). Jeong KW; Lee JH; Park SM; Choi JH; Jeong DY; Choi DH; Nam Y; Park JH; Lee KN; Kim SM; Ku JM Eur J Med Chem; 2015 Sep; 102():387-97. PubMed ID: 26301555 [TBL] [Abstract][Full Text] [Related]
18. Rapid and differential diagnosis of foot-and-mouth disease, swine vesicular disease, and vesicular stomatitis by a new multiplex RT-PCR assay. Fernández J; Agüero M; Romero L; Sánchez C; Belák S; Arias M; Sánchez-Vizcaíno JM J Virol Methods; 2008 Feb; 147(2):301-11. PubMed ID: 17964668 [TBL] [Abstract][Full Text] [Related]
19. Determinants of early foot-and-mouth disease virus dynamics in pigs. Quan M; Murphy CM; Zhang Z; Alexandersen S J Comp Pathol; 2004 Nov; 131(4):294-307. PubMed ID: 15511538 [TBL] [Abstract][Full Text] [Related]
20. Foot-and-mouth disease virus low-fidelity polymerase mutants are attenuated. Xie X; Wang H; Zeng J; Li C; Zhou G; Yang D; Yu L Arch Virol; 2014 Oct; 159(10):2641-50. PubMed ID: 24888311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]